Literature DB >> 25533920

Proteomic analysis of mitochondria in respiratory epithelial cells infected with human respiratory syncytial virus and functional implications for virus and cell biology.

Diane C Munday1, Gareth Howell, John N Barr, Julian A Hiscox.   

Abstract

OBJECTIVES: The aim of this study was to quantitatively characterise the mitochondrial proteome of airway epithelial cells infected with human respiratory syncytial virus (HRSV), a major cause of paediatric illness.
METHODS: Quantitative proteomics, underpinned by stable isotope labelling with amino acids in cell culture, coupled to LC-MS/MS, was applied to mitochondrial fractions prepared from HRSV-infected and mock-infected cells 12 and 24 h post-infection. Datasets were analysed using ingenuity pathway analysis, and the results were validated and characterised using bioimaging, targeted inhibition and gene depletion. KEY
FINDINGS: The data quantitatively indicated that antiviral signalling proteins converged on mitochondria during HRSV infection. The mitochondrial receptor protein Tom70 was found to act in an antiviral manner, while its chaperone, Hsp90, was confirmed to be a positive viral factor. Proteins associated with different organelles were also co-enriched in the mitochondrial fractions from HRSV-infected cells, suggesting that alterations in organelle dynamics and membrane associations occur during virus infection.
CONCLUSIONS: Protein and pathway-specific alterations occur to the mitochondrial proteome in a spatial and temporal manner during HRSV infection, suggesting that this organelle may have altered functions. These could be targeted as part of potential therapeutic strategies to disrupt virus biology.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  inhibition; mitochondria; proteomics; respiratory syncytial virus; siRNA

Mesh:

Substances:

Year:  2014        PMID: 25533920     DOI: 10.1111/jphp.12349

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Evolution of proteomics technologies for understanding respiratory syncytial virus pathogenesis.

Authors:  Morgan Mann; Allan R Brasier
Journal:  Expert Rev Proteomics       Date:  2021-05-31       Impact factor: 4.250

Review 2.  Chaperoning the Mononegavirales: Current Knowledge and Future Directions.

Authors:  Victor Latorre; Florian Mattenberger; Ron Geller
Journal:  Viruses       Date:  2018-12-08       Impact factor: 5.048

3.  Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production.

Authors:  Marie A Bogoyevitch; David A Jans; MengJie Hu; Keith E Schulze; Reena Ghildyal; Darren C Henstridge; Jacek L Kolanowski; Elizabeth J New; Yuning Hong; Alan C Hsu; Philip M Hansbro; Peter Ab Wark
Journal:  Elife       Date:  2019-06-27       Impact factor: 8.140

4.  The Interactome analysis of the Respiratory Syncytial Virus protein M2-1 suggests a new role in viral mRNA metabolism post-transcription.

Authors:  Camille Bouillier; Gina Cosentino; Thibaut Léger; Vincent Rincheval; Charles-Adrien Richard; Aurore Desquesnes; Delphine Sitterlin; Sabine Blouquit-Laye; Jean-Francois Eléouët; Elyanne Gault; Marie-Anne Rameix-Welti
Journal:  Sci Rep       Date:  2019-10-24       Impact factor: 4.379

Review 5.  Role of Mitochondria in Viral Infections.

Authors:  Srikanth Elesela; Nicholas W Lukacs
Journal:  Life (Basel)       Date:  2021-03-11

Review 6.  How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.

Authors:  Tessa Van Royen; Iebe Rossey; Koen Sedeyn; Bert Schepens; Xavier Saelens
Journal:  Viruses       Date:  2022-02-17       Impact factor: 5.048

7.  Subversion of Host Cell Mitochondria by RSV to Favor Virus Production is Dependent on Inhibition of Mitochondrial Complex I and ROS Generation.

Authors:  MengJie Hu; Marie A Bogoyevitch; David A Jans
Journal:  Cells       Date:  2019-11-11       Impact factor: 6.600

8.  Metabolic Reprogramming of Nasal Airway Epithelial Cells Following Infant Respiratory Syncytial Virus Infection.

Authors:  Andrew R Connelly; Brian M Jeong; Mackenzie E Coden; Jacob Y Cao; Tatiana Chirkova; Christian Rosas-Salazar; Jacqueline-Yvonne Cephus; Larry J Anderson; Dawn C Newcomb; Tina V Hartert; Sergejs Berdnikovs
Journal:  Viruses       Date:  2021-10-13       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.